AKV-9

DB18061ExperimentalSmall molecule

AKV-9: Overview.

Mechanism: Pharmacologically active on Amyloid-beta precursor protein
Curator reviewed
Formula / weight: C₁₆H₁₄F₆O₃ · 368.275 g/mol (avg)
Also known as: 1,3-Cyclohexanedione, 5-[(1S)-1-[3,5-bis(trifluoromethyl)phenoxy]ethyl]- · 5-((S)-1-(3,5-bis(trifluoromethyl)phenoxy)ethyl)-3-hydroxycyclohex-2-en-1-one · 5-[(1S)-1-[3,5-Bis(trifluoromethyl)phenoxy]ethyl]-1,3-cyclohexanedione
Code names: AKV-9 · NU-9

Resolves to

Compound

Structure

InChIKeyFVEVQUBFQXFSNY-QMMMGPOBSA-NSMILESC[C@H](OC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1CC(=O)CC(=O)C1

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with AKV-9, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.